Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 161

Similar articles for PubMed (Select 23098088)

1.

Oncologic outcomes using real-time peripheral thermometry-guided radiofrequency ablation of small renal masses.

Leveillee RJ, Castle SM, Gorbatiy V, Salas N, Narayanan G, Morillo-Burgos G, Jorda M, Faraday MM.

J Endourol. 2013 Apr;27(4):480-9. doi: 10.1089/end.2012.0305. Epub 2013 Mar 26.

PMID:
23098088
2.

Comparison of safety, renal function outcomes and efficacy of laparoscopic and percutaneous radio frequency ablation of renal masses.

Young EE, Castle SM, Gorbatiy V, Leveillee RJ.

J Urol. 2012 Apr;187(4):1177-82. doi: 10.1016/j.juro.2011.11.099. Epub 2012 Feb 20.

PMID:
22357170
3.

Durable oncologic outcomes after radiofrequency ablation: experience from treating 243 small renal masses over 7.5 years.

Tracy CR, Raman JD, Donnally C, Trimmer CK, Cadeddu JA.

Cancer. 2010 Jul 1;116(13):3135-42. doi: 10.1002/cncr.25002.

4.
5.

Laparoscopic radiofrequency ablation of small renal tumors: long-term oncologic outcomes.

Ramirez D, Ma YB, Bedir S, Antonelli JA, Cadeddu JA, Gahan JC.

J Endourol. 2014 Mar;28(3):330-4. doi: 10.1089/end.2013.0542. Epub 2013 Dec 28.

PMID:
24156661
6.

Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours.

Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ.

BJU Int. 2014 Mar;113(3):416-28. doi: 10.1111/bju.12349. Epub 2013 Oct 22.

7.

Management of renal masses with laparoscopic-guided radiofrequency ablation versus laparoscopic partial nephrectomy.

Bird VG, Carey RI, Ayyathurai R, Bird VY.

J Endourol. 2009 Jan;23(1):81-8. doi: 10.1089/end.2008.0087.

PMID:
19118475
8.

Laparoscopic radiofrequency ablation with intraoperative contrast-enhanced ultrasonography for T1bN0M0 renal tumors: initial functional and oncologic outcomes.

Yang R, Lian H, Zhang G, Wang W, Gan W, Li X, Yan X, Zhang S, Zhao X, Guo H.

J Endourol. 2014 Jan;28(1):4-9. doi: 10.1089/end.2013.0397. Epub 2013 Nov 20.

PMID:
23998802
10.

Cancer-free survival and local tumor control after impendence-based radiofrequency ablation of biopsy-proven renal cell carcinomas with a minimum of 1-year follow-up.

Forauer AR, Dewey BJ, Seigne JD.

Urol Oncol. 2014 Aug;32(6):869-76. doi: 10.1016/j.urolonc.2014.03.016. Epub 2014 Jun 16.

PMID:
24946958
11.

Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma.

Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA.

Eur Urol. 2013 Mar;63(3):486-92. doi: 10.1016/j.eururo.2012.08.062. Epub 2012 Sep 5.

PMID:
22959191
12.

General anesthesia and contrast-enhanced computed tomography to optimize renal percutaneous radiofrequency ablation: multi-institutional intermediate-term results.

Gupta A, Raman JD, Leveillee RJ, Wingo MS, Zeltser IS, Lotan Y, Trimmer C, Stern JM, Cadeddu JA.

J Endourol. 2009 Jul;23(7):1099-105. doi: 10.1089/end.2008.0499.

PMID:
19530948
13.

Long-term outcomes in healthy adults after radiofrequency ablation of T1a renal tumours.

Ma Y, Bedir S, Cadeddu JA, Gahan JC.

BJU Int. 2014 Jan;113(1):51-5. doi: 10.1111/bju.12366. Epub 2013 Nov 8.

PMID:
24053553
14.

Ultrasound-guided percutaneous radiofrequency ablation of small renal tumors: Clinical results and radiological evolution during follow-up.

Lyrdal D, Andersson M, Hellström M, Sternal J, Lundstam S.

Acta Radiol. 2010 Sep;51(7):808-18. doi: 10.3109/02841851.2010.489054.

PMID:
20707665
15.

Preoperative patient counseling for diagnostic renal biopsy and complications with renal radiofrequency ablation.

Castle SM, Gorin MA, Gorbatiy V, Leveillee RJ.

World J Urol. 2013 Oct;31(5):1105-10. doi: 10.1007/s00345-012-0823-3. Epub 2012 Jan 15.

PMID:
22249341
16.

Cost comparison of nephron-sparing treatments for cT1a renal masses.

Castle SM, Gorbatiy V, Avallone MA, Eldefrawy A, Caulton DE, Leveillee RJ.

Urol Oncol. 2013 Oct;31(7):1327-32. doi: 10.1016/j.urolonc.2012.01.006. Epub 2012 Feb 22.

PMID:
22361086
17.

Short-term efficacy of temperature-based radiofrequency ablation of small renal tumors.

Matsumoto ED, Johnson DB, Ogan K, Trimmer C, Sagalowsky A, Margulis V, Cadeddu JA.

Urology. 2005 May;65(5):877-81.

PMID:
15882715
18.

Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.

Olweny EO, Park SK, Tan YK, Best SL, Trimmer C, Cadeddu JA.

Eur Urol. 2012 Jun;61(6):1156-61. doi: 10.1016/j.eururo.2012.01.001. Epub 2012 Jan 10.

PMID:
22257424
19.

Percutaneous ablation of renal masses measuring 3.0 cm and smaller: comparative local control and complications after radiofrequency ablation and cryoablation.

Atwell TD, Schmit GD, Boorjian SA, Mandrekar J, Kurup AN, Weisbrod AJ, Chow GK, Leibovich BC, Callstrom MR, Patterson DE, Lohse CM, Thompson RH.

AJR Am J Roentgenol. 2013 Feb;200(2):461-6. doi: 10.2214/AJR.12.8618.

PMID:
23345372
20.

Ten-year experience of percutaneous image-guided radiofrequency ablation of malignant renal tumours in high-risk patients.

Balageas P, Cornelis F, Le Bras Y, Hubrecht R, Bernhard JC, Ferrière JM, Ravaud A, Grenier N.

Eur Radiol. 2013 Jul;23(7):1925-32. doi: 10.1007/s00330-013-2784-3. Epub 2013 Feb 27.

PMID:
23443351
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk